Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Kohei SomekawaKeisuke WatanabeKenichi SekiSuguru MuraokaAmi IzawaAyami KanekoYukiko OtsuMomo HirataSousuke KuboKatsushi TanakaRyo NagasawaHiromi MatsumotoKota MurohashiHiroaki FujiAyako AokiNobuyuki HoritaYu HaraNobuaki KobayashiMakoto KudoTakeshi Kaneko

Published in: European clinical respiratory journal (2024)

Benralizumab reduced the annual number of asthma exacerbations and was well tolerated in elderly patients.

Keyphrases

chronic obstructive pulmonary disease
lung function
allergic rhinitis
cystic fibrosis
early onset
middle aged
air pollution